Tirzepatide × NextGen Peptides - Lab Test, January 2026
Test results
About this test
Tirzepatide 30mg from NextGen Peptides achieves 98.825% purity according to this independent HPLC analysis conducted by Janoshik Labs on January 16, 2026. The tested quantity was 35.17mg, exceeding the stated label amount of 30mg.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 98.825% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (Task #100040) is available for verification at www.janoshik.com/verify/ with the unique key 5EYFPBJCXKB. The test includes assessment of the peptide vial or vials.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.